NK Cell Therapies Pipeline Report 2024: Insights on 80+ Companies and 100+ Pipeline Drugs, Including ALECSAT (CytoVac), NKTR-214/Bempegaldesleukin (Nektar Therapeutics), and Monalizumab (Innate Pharma)

Yahoo FinanceApr 26 16:12

Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Innate Pharma SA (OtherIPHYF) and Neumora Therapeutics, Inc. (NMRA)

TipRanksApr 17 16:10

Innate Pharma's NK Cell Engager Enters Phase 2 Trials

TipRanksApr 16 09:00

Innate Pharma Announces Upcoming Annual General Meeting

Innate Pharma S.A., a clinical-stage biotechnology company, has announced its Annual General Meeting (AGM) scheduled for May 23, 2024, at its Marseille headquarters. Shareholders are invited to participate in the AGM and a guided tour of the company’s laboratories, with preparatory documents available on Innate’s website.

TipRanksApr 16 09:00

Sezary Syndrome Pipeline Insights 2024, Featuring Major Players 4SC, Seagen, Merck Sharp & Dohme, Innate Pharma, Trillium Therapeutics and Secura Bio

Yahoo FinanceApr 15 22:07

Innate Pharma Advances Sanofi-Developed NK Cell Engager SAR443579 / IPH6101 Progressing To Phase 2 For Blood Cancer Patients

Innate Pharma Advances Sanofi-Developed NK Cell Engager SAR443579 / IPH6101 Progressing To Phase 2 For Blood Cancer Patients

BenzingaApr 15 13:47